ASX - By Stock
|
BOT |
Re:
BOT-what's next
|
|
DevPerspective
|
4 |
2.1K |
1 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
4
|
2.1K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
DevPerspective
|
8.9K |
3.3M |
9 |
03/01/21 |
03/01/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 2A and Notice Under Section 708A
|
|
DevPerspective
|
36 |
15K |
1 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
36
|
15K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 2A and Notice Under Section 708A
|
|
DevPerspective
|
36 |
15K |
1 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
36
|
15K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 2A and Notice Under Section 708A
|
|
DevPerspective
|
36 |
15K |
3 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
36
|
15K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 2A and Notice Under Section 708A
|
|
DevPerspective
|
36 |
15K |
1 |
21/12/20 |
21/12/20 |
ASX - By Stock
|
36
|
15K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1801 Phase 2a Antimicrobial Study Underway
|
|
DevPerspective
|
291 |
126K |
8 |
14/11/20 |
14/11/20 |
ASX - By Stock
|
291
|
126K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1801 Phase 2a Antimicrobial Study Underway
|
|
DevPerspective
|
291 |
126K |
9 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
291
|
126K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
DevPerspective
|
25 |
10K |
3 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
25
|
10K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
1 |
29/08/20 |
29/08/20 |
ASX - By Stock
|
13K
|
4.6M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Response to ASX Aware Query
|
|
DevPerspective
|
41 |
17K |
2 |
26/07/20 |
26/07/20 |
ASX - By Stock
|
41
|
17K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
No news but up 10%
|
|
DevPerspective
|
50 |
18K |
0 |
26/07/20 |
26/07/20 |
ASX - By Stock
|
50
|
18K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
No news but up 10%
|
|
DevPerspective
|
50 |
18K |
1 |
26/07/20 |
26/07/20 |
ASX - By Stock
|
50
|
18K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1503 End of Phase 2 Milestone with FDA
|
|
DevPerspective
|
186 |
53K |
1 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
186
|
53K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 3G
|
|
DevPerspective
|
3 |
1.8K |
1 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
3
|
1.8K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Antimicrobial platform - BTX 1801 Phase 2a clinical study
|
|
DevPerspective
|
125 |
57K |
5 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
125
|
57K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
4 |
28/06/20 |
28/06/20 |
ASX - By Stock
|
13K
|
4.6M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
12 |
28/06/20 |
28/06/20 |
ASX - By Stock
|
13K
|
4.6M
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
7 |
28/06/20 |
28/06/20 |
ASX - By Stock
|
13K
|
4.6M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
5 |
28/06/20 |
28/06/20 |
ASX - By Stock
|
13K
|
4.6M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
5 |
27/06/20 |
27/06/20 |
ASX - By Stock
|
13K
|
4.6M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
5 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
13K
|
4.6M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
2 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
13K
|
4.6M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
1 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
13K
|
4.6M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Provides Update on Development Activities
|
|
DevPerspective
|
23 |
9.9K |
4 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
23
|
9.9K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Antimicrobial platform - BTX 1801 Phase 2a clinical study
|
|
DevPerspective
|
125 |
57K |
8 |
19/06/20 |
19/06/20 |
ASX - By Stock
|
125
|
57K
|
8
|
|
ASX - By Stock
|
CSL |
Re:
Coronavirus
|
|
DevPerspective
|
140 |
172K |
4 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
140
|
172K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Antimicrobial platform - BTX 1801 Phase 2a clinical study
|
|
DevPerspective
|
125 |
57K |
14 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
125
|
57K
|
14
|
|
ASX - By Stock
|
BOT |
Re:
Antimicrobial platform - BTX 1801 Phase 2a clinical study
|
|
DevPerspective
|
125 |
57K |
3 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
125
|
57K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
1 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
13K
|
4.6M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
4 |
30/05/20 |
30/05/20 |
ASX - By Stock
|
13K
|
4.6M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
7 |
30/05/20 |
30/05/20 |
ASX - By Stock
|
13K
|
4.6M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
4 |
30/05/20 |
30/05/20 |
ASX - By Stock
|
13K
|
4.6M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
2 |
30/05/20 |
30/05/20 |
ASX - By Stock
|
13K
|
4.6M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
4 |
30/05/20 |
30/05/20 |
ASX - By Stock
|
13K
|
4.6M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
4 |
30/05/20 |
30/05/20 |
ASX - By Stock
|
13K
|
4.6M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
5 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
13K
|
4.6M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
DevPerspective
|
13K |
4.6M |
3 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
13K
|
4.6M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Clinical trials.gov update
|
|
DevPerspective
|
44 |
29K |
0 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
44
|
29K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
DevPerspective
|
56 |
17K |
11 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
56
|
17K
|
11
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Bronchitol NDA Resubmission - FDA Decision Date 1 November
|
|
DevPerspective
|
7 |
4.9K |
0 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
7
|
4.9K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
DevPerspective
|
56 |
17K |
7 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
56
|
17K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
DevPerspective
|
56 |
17K |
1 |
23/05/20 |
23/05/20 |
ASX - By Stock
|
56
|
17K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
DevPerspective
|
56 |
17K |
4 |
23/05/20 |
23/05/20 |
ASX - By Stock
|
56
|
17K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Change of Director's Interest Notice MT
|
|
DevPerspective
|
3 |
3.5K |
1 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
3
|
3.5K
|
1
|
|